MHRA: Drug Safety Update(March 2020): Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression

MHRA: Drug Safety Update(March 2020): SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness

 MHRA: Drug Safety Update (March2020): Baricitinib (Olumiant▼): risk of venous thromboembolism

MHRA: Drug Saftey Update (March 2020): Tofacitinib (Xeljanz▼): new measures to minimise risk of venous thromboembolism and of serious and fatal infections

MHRA:Drug Safety Update (March 2020): Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury

COVID-19: useful links